View Older Stories View More Recent Stories

Aug 6, 2020 04:05PM NantHealth Reports 2020 Second Quarter Financial Results
Aug 3, 2020 11:47AM NantHealth to Report 2020 Second-Quarter Financial Results and Host Conference Call on Thursday, August 6
Jul 27, 2020 08:02AM NantHealth (NH) Acquires OpenNMS
Jul 27, 2020 08:00AM NantHealth Acquires OpenNMS, the World’s Largest Open Source Network Management Application Platform
Jun 25, 2020 08:00AM NantHealth Announces Research Results that Advances Understanding of Tumor Treatment Resistance
Jun 18, 2020 04:00PM NantHealth Presented Clinical Data on Immunotherapy, Molecularly Targeted Agents and Tumor Biology at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
Jun 16, 2020 11:24AM NantHealth to Exhibit at Virtual America’s Health Insurance Plans (AHIP) Institute & Expo 2020 with Webinars to Follow
May 8, 2020 04:30PM In Recognition of the Challenges Providers Are Facing, NantHealth is Offering Free Access to NaviNet AllPayer for a Limited Time
May 7, 2020 04:05PM NantHealth Reports 2020 First Quarter Financial Results
May 4, 2020 06:52AM NantHealth to Report 2020 First-quarter Financial Results and Host Conference Call on Thursday, May 7
Mar 12, 2020 08:00AM NantHealth Announces Appointment of Deanna L. Wise to Its Board of Directors
Feb 28, 2020 04:05PM NantHealth Reports 2019 Fourth-quarter, Full-year Financial Results
Feb 27, 2020 08:00AM NantHealth’s Cancer Therapy Pre-Authorization Platform Eviti Connect® Starts 2020 Strong with Two Expanded Programs
Feb 25, 2020 08:00AM Dr. Patrick Soon-Shiong to Deliver Keynote at HIMSS 2020 Intelligent Health™ Pavilion
Feb 24, 2020 06:54AM NantHealth to Report 2019 Fourth-Quarter Financial Results and Host Conference Call on Friday, February 28
Feb 19, 2020 08:00AM NantOmics and NantHealth Announce Results of Proprietary Machine Vision AI Software Study Demonstrating the Ability to Identify Aggressive Subtypes of Breast Cancer From Digital Pathology Images
Feb 19, 2020 08:00AM NantOmics and NantHealth Announce Results of Proprietary Machine Vision AI Software Study Demonstrating the Ability to Identify Aggressive Subtypes of Breast Cancer From Digital Pathology Images
Jan 28, 2020 09:12AM NantHealth (NH) Announces Health Plan Serving Over 200,000 Covered Lives Selects its NaviNet Open to Drive Provider Engagement Strategy
Jan 28, 2020 08:00AM The Health Plan Serving Over 200,000 Covered Lives Selects NantHealth’s NaviNet® Open to Drive Provider Engagement Strategy
Jan 28, 2020 08:00AM The Health Plan Serving Over 200,000 Covered Lives Selects NantHealth’s NaviNet® Open to Drive Provider Engagement Strategy
Jan 27, 2020 07:10PM NantHealth and NantOmics Reveal a Novel AI Based Machine-Learning Digital Pathology Software for Lung Cancer by Identifying Tumor Infiltrating Killer Cells From Whole Slide Images
Jan 25, 2020 09:30AM NantHealth’s Eviti Connect Data Shows Recycling of Chemotherapy and Biologics for Advanced CRC Patients More Common Than Switching to Drug Regimens with Alternative Mechanism of Action
Jan 25, 2020 09:30AM Data from NantHealth’s GPS Cancer platform reveals increased opportunities for HER2 directed therapy in colorectal cancer patients
Jan 14, 2020 09:01AM Masimo Corp. (MASI) to Acquire Connected Care Business from NantHealth (NH) for $47.25 Million
Jan 14, 2020 09:00AM Masimo to Acquire Connected Care Business from NantHealth
Dec 11, 2019 06:00PM NantHealth Presents Research Demonstrating Real World Evidence of Simultaneous Presentation and Publication of Oncology Data at the 2019 San Antonio Breast Cancer Symposium
Nov 12, 2019 08:00AM NantHealth Announces FDA Marketing Authorization of Omics Core℠: The Nation’s First Tumor-Normal Mutation Profiling of Overall Tumor Mutational Burden from Whole Exome Sequencing in Solid Tumors
Nov 12, 2019 08:00AM NantHealth Announces FDA Marketing Authorization of Omics Core℠: The Nation’s First Tumor-Normal Mutation Profiling of Overall Tumor Mutational Burden from Whole Exome Sequencing in Solid Tumors
Nov 7, 2019 04:15PM NantHealth Reports 2019 Third-Quarter Financial Results
Oct 30, 2019 06:54AM NantHealth to Report 2019 Third-quarter Financial Results and Host Conference Call on Thursday, November 7
Oct 23, 2019 05:00AM Wexford Health Sources, Inc. Selects NantHealth’s Eviti® Connect to Bring Evidence-Based Standards and Value-Based Oncology Care to Patients
Oct 4, 2019 08:00AM NantHealth®, GE Healthcare, AirStrip and iProcedures Join Forces to Present at the HIMSS Asia Pacific 2019 Conference
Sep 26, 2019 04:30AM NantHealth Announces New Product Updates to Help Reduce Patient Overstays and Facilitate Faster Decision Making at AMSN’s 28th Annual Convention
Aug 27, 2019 08:00AM NantHealth’s Eviti Platform Again Granted Full URAC Accreditation, Through September 1, 2022
Aug 8, 2019 04:15PM NantHealth Reports 2019 Second-Quarter Financial Results
Jun 19, 2019 11:00AM NantHealth to Exhibit at America’s Health Insurance Plans (AHIP) Institute & Expo 2019
Jun 13, 2019 08:00AM CareSource, One of the Nation’s Largest Medicaid Managed Care Plans, Selects NantHealth’s Eviti® Connect to Provide Members with Quality, Value-Based Oncology Care
Jun 12, 2019 01:00AM NantHealth® Showcases Leading Health Care Technology Solutions at First U.S. Pavilion at HIMSS & Health 2.0 European Conference
Jun 11, 2019 01:46AM NantHealth® Showcases Connected Care Products at HIMSS & Health 2.0 European Conference 2019
May 21, 2019 11:15AM NantHealth® Showcases DeviceConX™ Version 5.15 at Vitalis, Largest eHealth Event in Scandinavia
May 21, 2019 11:08AM NantHealth Discusses the Importance of Medical Device Integration at Vitalis 2019
May 9, 2019 04:15PM NantHealth Reports 2019 First-Quarter Financial Results
Feb 11, 2019 08:00AM Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU
Aug 27, 2018 08:00AM Using the Technology That Powers GPS Cancer™, Scientists Have Developed Fresh Insights into the Driving Mechanisms of a Rare Skin Cancer
Aug 27, 2018 08:00AM Using the Technology That Powers GPS Cancer™, Scientists Have Developed Fresh Insights into the Driving Mechanisms of a Rare Skin Cancer
Jun 2, 2018 05:23PM NantHealth and NantOmics to Present Data on the Frequency of Non-Expressed Variants Tested by Standard NGS Panel at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Jun 2, 2018 05:19PM NantHealth and NantOmics to Present Patterns of Immune Checkpoint Molecules in Relation to PD-L1 Expression at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Jun 2, 2018 05:03PM NantHealth and NantOmics to Present Data on Three-Fold Overestimation of Tumor Mutation Burden Using Gene Panel vs Whole Exome at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Jun 2, 2018 05:02PM NantHealth and NantOmics to Share Data on Next-Generation Sequencing of Paired DNA and RNA Analysis of Rare Tumors at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
May 21, 2018 12:30PM NantOmics Announces Study Showing Signature Analysis That Reveals Three Distinct Classifications of Skin Cancer Known as Sebaceous Carcinoma
View More Recent Stories View Older Stories